KARLI SEEFRIED: Open Payments
NPI 1437438322 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 66 payments from 16 companies in 2025. Trend: 2023 $100 · 2024 $0 · 2025 $1,029
Food & beverage: $1,029
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $304 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $100 |
| Lilly USA, LLC | 5 | $92 |
| PFIZER INC. | 5 | $85 |
| Novo Nordisk Inc | 4 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $43 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Exact Sciences Corporation | 2 | $35 |
Products named: UBRELVY, CAPLYTA, JARDIANCE, QULIPTA, VRAYLAR, TRINTELLIX, VOQUEZNA, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
